The medical record and Apgar scores from the birth were not available. According to his mother, the patient's birth height and weight were within the normal range for his age. The postnatal course was uneventful; however, the patient was small for his age during infancy and was always the smallest boy (below the third percentile) in his classes during school (Fig. 2 ). The patient was within the normal range of intelligence quotient throughout his school days.
Past medical history:
The patient was diagnosed as having hepatitis B antigenemia at 14 years of age. hematocrit, 29%; platelets, 1.5 × 10 9 /L; total protein, 74 (67~86 g/L); albumin, 42 (40~50 g/L); total bilirubin, 6.8 during the previous and current visit indicated that the patient had CPHD ( Table 1 ). The patient's karyotype was 46 XY. We performed pituitary transcription factor gene mutation analysis (Hesx1, SOX3, LHX3, PROP1 and PIT1); however, the results were negative.
Imaging findings: Sellar MRI performed during the current visit showed findings similar to the previous ones obtained four years before, i.e., a hypoplastic stalk and hypophyseal gland ( hepatitis B antigenemia and highly elevated levels of IGF-II prompted us to order liver computed tomography (CT), ultrasonography and colonoscopy. These studies did not detect any lesions except mild fatty liver and hepatosplenomegaly. At present, the patient is being followed as an outpatient and is taking oral prednisolone acetate 2.5 mg and testosterone undecanoate 160 mg daily.
He has no specific complaints.
Discussion
The patient was a typical case of idiopathic CPHD IGF regulates cell growth and differentiation in humans and many species. The anabolic functions of GH are largely mediated by IGF-I, thus designating IGF-I as a major determinant of somatic growth [16] . IGF-I levels are more GH-dependent than IGF-II levels and are more likely to reflect subtle differences in GH secretory patterns. The main pathogenic mechanisms of IGF-II over-expression are loss of IGF-II imprinting and gene duplication [16] .
Sonic hedgehog, which plays a key role in regulating vertebrate organogenesis, can also transcriptionally activate the IGF-II gene [16] . IGF-II is widely expressed during murine embryonic development and is particularly important in placental growth [17] . IGF-II-null mice, which possess a normal GH-IGF-I system, are growth-impaired at birth but subsequent growth proceeds at normal rates [18] . IGF-II is virtually dispensable for post-natal development in mice. IGF-II can stimulate cellular proliferation and differentiation through insulin receptor and IGF-I receptor binding [16] . IGF-II also promotes the proliferation and differentiation of myocytes and bone cells in vitro [19, 20] . IGF-II exerts its growth-promoting activity predominantly during fetal development. However, the elevated IGF-II levels suggest that it has postnatal activity.
Patients with severe liver disease, such as liver cirrhosis, may have lower serum IGF-I levels than healthy individuals [21] . It was not likely that our patient's liver function caused a decreased serum IGF-1 level, because our patient was a hepatitis B carrier with normal liver function (Child-Pugh score 5). IGF-1 variant exhibits very weak binding to IGF-binding proteins and is substantially more potent than the natural growth factor [22] . We could not completely exclude the possibility that the IGF-1 variant induced continuous linear growth in the patient.
In conclusion, this report describes a 22-year-old male with accelerated growth despite CPHD. We suggest that elevated IGF-II may have contributed to normal growth, in part, following prolonged hypogonadism. The role of elevated IGF-II production and its possible effects on the patient's growth remain to be evaluated. 
